AQP4 and neuromyelitis optica: Noting that NMO clinical symptoms and the presence of the pathogenic anti-AQP4 antibodies have recently been reported in patients with MG [9, 12] and that anti-AChR antibodies were found in 11% of NMO patients [10], we examined whether and how one disease affects the severity of the autoimmune course of the other disease.